Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

180 results
Display

A Case of Breast Carcinoma with Leser-Trelat Sign Responding to Tamoxifen

Ko BJ, Jung GH, Lee SH, Cho MK, Lee JS, Lee SY

  • KMID: 2089048
  • Korean J Dermatol.
  • 2014 Sep;52(9):672-673.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tamoxifen Resistance and Crosstalk of Signal Transduction in Breast Cancer

Park WC

In the hormonal therapy of breast cancer, tamoxifen is currently the standard treatment for estrogen receptor (ER)-positive patients. A response to tamoxifen has been reported in only 2/3 of patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of calcitonin, NaF and tamoxifen on osteoporosis induced by ovariectomy in rat

Lee HM, Park BM, Kim HN

  • KMID: 1691075
  • J Korean Orthop Assoc.
  • 1993 Oct;28(6):2273-2280.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cases with Endometrial Polyp and Endocervical Polyp Associated With Tamoxifen Use

Choe BH, Choi EK, Kim YT, Kim JW, Park BW

  • KMID: 2261907
  • Korean J Obstet Gynecol.
  • 2000 Apr;43(4):725-730.
Tamoxifen is a nonsteroidal triphenylethylene delivative that has been widely used in the treatment of breast cancer. tamoxifen is indicated for the adjuvant treatment of breast cancer in women following total...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of tamoxifen and 17beta-estradiol on the growth of human cervical and ovarian cancer cells in vitro

Park LO, Ro DY, Kim JW, Kim DK, Kim DH, Kim SJ

  • KMID: 1696492
  • Korean J Obstet Gynecol.
  • 1991 Jan;34(1):63-69.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Change of Endometrial Thickness in Tamoxifen-treated Postmenopausal Breast Cancer Patients

Park JW, Kang YD, Ryu JW

  • KMID: 2272375
  • Korean J Obstet Gynecol.
  • 2004 Jun;47(6):1199-1203.
OBJECTIVE: The aim of this study is to investigate the effect of tamoxifen on endometrial thickness in postmenopausal women taking adjuvant tamoxifen therapy for breast cancer after chemotherapy. METHODS: Fifty-eight tamoxifen-treated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer

Yu D, Shi L, Bu Y, Li W

PURPOSE: Breast cancer (BC) is one of the most common malignancies globally, and millions of women worldwide are diagnosed with BC every year. Up to 70% of BC patients are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Endometrial Carcinoma in Tamoxifen-treated Breast Cancer Patients in Korea

Park WC, Lee DH, Choi SH, Kim JS, Oh SJ, Jung SS, Lee JH, Kim IC

Tamoxifen, the representative of selective estrogen receptor modulaor (SERM), has been widely used not only for the treatment of breast cancer, but also for the prevention of the disease. It...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tamoxifen Only versus L-Carnitine and Tamoxifen in the Oral Therapy of Peyronie's Disease

Yoon CJ, Moon KH

  • KMID: 2299439
  • Korean J Androl.
  • 2006 Apr;24(1):8-12.
PURPOSE: To evaluate the effects of oral Tamoxifen only versus L-Carnitine plus Tamoxifen in patients with Peyronie's disease. MATERIALS AND METHODS: All 45 patients with Peyronie's disease, diagnosed using accepted...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
In vitro respones of gynecological cancer cell lines to the GnRH agonist, medroxyprogesterone acetate and tamoxifen

Sohn JW, Prk JK, Lee SK, Kim SB, Oh BH

  • KMID: 1697795
  • Korean J Obstet Gynecol.
  • 1993 Sep;36(9):3436-3443.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Brain Stem Glioma Responded to Tamoxifen after Relapse with Chemotherapy and Radiotherapy

Choi SW, Nam SG

  • KMID: 1535342
  • Korean J Pediatr Hematol Oncol.
  • 1998 Oct;5(2):353-357.
Tamoxifen is an oral triphenylethylene antiestrogen that has been used for breast cancer, but also inhibits protein kinase C(PKC) in a minority of malignant gliomas. Tamoxifen was administered orally in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Retinopathy and Keratopathy Associated with Chronic Tamoxifen Medication

Suhk HJ, Sohn JH, Yoon YH

  • KMID: 2125269
  • J Korean Ophthalmol Soc.
  • 2002 Nov;43(11):2354-2359.
PURPOSE: Tamoxifen retinopathy is one of the uncommon side effects together with keratopathy, crystalline retinopathy and cystoid macula edema when tamoxifen is administered with high dose to breast cancer patients....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mammographic Changes in Breast Cancer Patients Treated with Tamoxifen

Kim JK, Oh KK, Kim TH, Lee HD

  • KMID: 2102982
  • J Korean Radiol Soc.
  • 1997 Sep;37(3):555-559.
PURPOSE: To evaluate the efficacy of tamoxifen, as shown by mammographic changes. MATERIALS AND METHODS: We studied the mammograms of 20 breast cancer patients treated with tamoxifen (20mg/day) and 20...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of carcinosarcoma of uterine endometrium associated with Tamoxifen use in breast cancer patient

Ahn JM, Kim SA, Lee SM, Lee YH, Kim DW, Chung JK, Kim SU, Joe HS, Lee IS, Kim DW

  • KMID: 2076660
  • Korean J Obstet Gynecol.
  • 2002 Jul;45(7):1236-1240.
Tamoxifen, which is often used in breast cancer therapy, has also been used in the treatment of patients with advanced and recurrent endometrial carcinoma. Tamoxifen has been shown to have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypertriglyceridemia-induced Severe Necrotizing Pancreatitis Following Low Dose Tamoxifen Administration

Jang YH, Kim HJ

A 51-year-old woman visited the emergency room with severe abdominal pain of acute onset. She had undergone a breast cancer operation one year previously and had been taking a half-dose...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estimating the Risks and Benefits of Tamoxifen for Prophylactic Breast Cancer Chemoprevention in Korea

Kim DU, Min JW, Kim YM, Chang MC

PURPOSE: According to the National Surgical Adjuvant Breast and Bowel Project P1 (NSABP-P1) study, tamoxifen can prevent 49% of invasive breast cancers in patients who have a 5-year risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Tamoxifen in C6 Glioma Cells

Yoo CJ, Lee U, Kim YB, Kang DS, Park CW, Yoo YM

  • KMID: 2044464
  • J Korean Neurosurg Soc.
  • 1997 Jan;26(1):5-10.
This work describes tamaoxifen, a nonsteroidal antiestrogen compound, which has been used extensively in the treatment of breast cancer on account of its efficacy and relatively low toxicity. It has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of Tamoxifen on Patients with Gynecomastia

Oh JM, Won TW

PURPOSE: Gynecomastia is the most common cause of male breast enlargement and is a disease which can occur in men of all ages. The purpose of this study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study on Hysteroscopic and Histologic Examinations of the Endometrium in Postmenopausal Women Taking Tamoxifen

Jung H, Jung JK, Kim SB, Cho EA, Um MJ

OBJECTIVES: To evaluate the histologic effects of tamoxifen on the endometrium using hysteroscopy in postmenopausal women with breast cancer. METHODS: The study included 46 postmenopausal patients who were referred from another...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis

Kim TH, Kim YB, Cheong JY, Cho SW, Kim SS

Non-alcoholic fatty liver disease has been observed in over 30% of patients who have received tamoxifen therapy. However, tamoxifen-induced non-alcoholic steatohepatitis (NASH) cirrhosis has never been reported in Korea. A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr